Massive Bio

Massive Bio is an Artificial Intelligence-driven company, offering an end-to-end platform, built to tackle cancer clinical trial enrollment inefficiencies, helping patients and their physicians get enrolled to the right clinical trial within hours instead of days. We are the official cancer clinical trial pre-screening vendor of the National Cancer Institute, and we have partnered with multiple pharmaceutical companies, as well as oncologists across the US to help as many patients as possible. Massive Bio partners with pharmaceutical companies for patient recruitment of hard-to-recruit studies, site selection, and Just-In-Time site activation while providing real world data. We provide an in-depth due diligence analysis for every trial, sharing important insights to enhance the success of patient recruitment. Once Massive Bio refers a patient, screen failures are reduced at the site through our AI-based Precision Oncology Clinical Trial Matching and Registry. Trial education and awareness is also increased through Massive Bio's provider network outreach and relationships with various advocacy groups. Massive Bio provides physicians with no-cost operating model optimization by streamlining the process of medical records retrieval, prescreening, referrals, and Just-In-Time activation for thousands of cancer patients potentially seeking care at your centers, enabling a new source of referrals model to achieve sufficient scope and deliver value at scale to your research network stakeholders. We can assist physicians by bringing new trials to your sites, while also offering AI pre-screening services, reducing screen failures and time and effort at the site, and further increasing enrollment. We also provide a dedicated, advanced trained, registered nurse who will support you and your busy staff in managing the referral process. All of this may come at no-cost to you or your patients, and with no increase to the operational or technological complexity of your practice.... More Info Less Info